Anti-inflammatory therapy in Alzheimer’s disease: is hope still alive? (original) (raw)

Abstract.

Based on observations from neuropathology, epidemiology, and in vitro and animal experiments, the inflammatory component of Alzheimer’s disease (AD) has been considered a compelling target for therapeutic intervention. However, a summary of all published trial reports to date suggests that AD patients do not benefit from treatment with anti-inflammatory drugs. In this brief review, we try to reconcile these sobering trial results with recent observations from basic research and epidemiology that continue to strengthen the idea that inflammatory mechanisms play an important role in the pathogenesis of AD. We review the possibilities that (1) not all components of the inflammatory response in AD are detrimental, (2) beneficial effects of anti-inflammatory drugs may not be mediated by inflammatory pathways, and (3) the timing of the intervention should be in the earliest stages of the pathogenesis of AD, perhaps even before the first symptoms emerge.We conclude that studies on primary prevention of AD are the logical next step in testing the inflammatory hypothesis of AD.

Access this article

Log in via an institution

Subscribe and save

• Get 10 units per month
• Download Article/Chapter or eBook
• 1 Unit = 1 Article or 1 Chapter
• Cancel anytime Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

1. Dept. of Neurology, Georgetown University Medical Centre, Washington DC, USA
   P. S. Aisen
2. Dept. of Neurology, H2–222.2, Academic Medical Center, 22700, 1100 DE, Amsterdam, The Netherlands
   W. A. van Gool & P. Eikelenboom

Authors

1. W. A. van Gool
   You can also search for this author inPubMed Google Scholar
2. P. S. Aisen
   You can also search for this author inPubMed Google Scholar
3. P. Eikelenboom
   You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to W. A. van Gool.

Rights and permissions

About this article

Cite this article

van Gool, W.A., Aisen, P.S. & Eikelenboom, P. Anti-inflammatory therapy in Alzheimer’s disease: is hope still alive?.J Neurol 250, 788–792 (2003). https://doi.org/10.1007/s00415-003-1146-5

Download citation

• Received: 15 January 2003
• Revised: 20 March 2003
• Accepted: 27 March 2003
• Issue Date: July 2003
• DOI: https://doi.org/10.1007/s00415-003-1146-5

Key words